BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20976000)

  • 81. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.
    McCredie MR; Sharples KJ; Paul C; Baranyai J; Medley G; Jones RW; Skegg DC
    Lancet Oncol; 2008 May; 9(5):425-34. PubMed ID: 18407790
    [TBL] [Abstract][Full Text] [Related]  

  • 82. An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).
    Castle PE; Cox JT; Jeronimo J; Solomon D; Wheeler CM; Gravitt PE; Schiffman M
    Obstet Gynecol; 2008 Apr; 111(4):847-56. PubMed ID: 18378743
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.
    Rodríguez AC; Schiffman M; Herrero R; Wacholder S; Hildesheim A; Castle PE; Solomon D; Burk R;
    J Natl Cancer Inst; 2008 Apr; 100(7):513-7. PubMed ID: 18364507
    [TBL] [Abstract][Full Text] [Related]  

  • 84. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.
    Carreon JD; Sherman ME; Guillén D; Solomon D; Herrero R; Jerónimo J; Wacholder S; Rodríguez AC; Morales J; Hutchinson M; Burk RD; Schiffman M
    Int J Gynecol Pathol; 2007 Oct; 26(4):441-6. PubMed ID: 17885496
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.
    Grulich AE; van Leeuwen MT; Falster MO; Vajdic CM
    Lancet; 2007 Jul; 370(9581):59-67. PubMed ID: 17617273
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.
    Plummer M; Schiffman M; Castle PE; Maucort-Boulch D; Wheeler CM;
    J Infect Dis; 2007 Jun; 195(11):1582-9. PubMed ID: 17471427
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report.
    Castle PE; Stoler MH; Solomon D; Schiffman M
    Am J Clin Pathol; 2007 May; 127(5):805-15. PubMed ID: 17439841
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Age-related changes of the cervix influence human papillomavirus type distribution.
    Castle PE; Jeronimo J; Schiffman M; Herrero R; Rodríguez AC; Bratti MC; Hildesheim A; Wacholder S; Long LR; Neve L; Pfeiffer R; Burk RD
    Cancer Res; 2006 Jan; 66(2):1218-24. PubMed ID: 16424061
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
    J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse.
    Pretorius RG; Zhang WH; Belinson JL; Huang MN; Wu LY; Zhang X; Qiao YL
    Am J Obstet Gynecol; 2004 Aug; 191(2):430-4. PubMed ID: 15343217
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A population-based study of vaginal human papillomavirus infection in hysterectomized women.
    Castle PE; Schiffman M; Bratti MC; Hildesheim A; Herrero R; Hutchinson ML; Rodriguez AC; Wacholder S; Sherman ME; Kendall H; Viscidi RP; Jeronimo J; Schussler JE; Burk RD
    J Infect Dis; 2004 Aug; 190(3):458-67. PubMed ID: 15243917
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.
    Strickler HD; Palefsky JM; Shah KV; Anastos K; Klein RS; Minkoff H; Duerr A; Massad LS; Celentano DD; Hall C; Fazzari M; Cu-Uvin S; Bacon M; Schuman P; Levine AM; Durante AJ; Gange S; Melnick S; Burk RD
    J Natl Cancer Inst; 2003 Jul; 95(14):1062-71. PubMed ID: 12865452
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
    Castellsagué X; Muñoz N
    J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Epidemiologic classification of human papillomavirus types associated with cervical cancer.
    Muñoz N; Bosch FX; de Sanjosé S; Herrero R; Castellsagué X; Shah KV; Snijders PJ; Meijer CJ;
    N Engl J Med; 2003 Feb; 348(6):518-27. PubMed ID: 12571259
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Adding a test for human papillomavirus DNA to cervical-cancer screening.
    Wright TC; Schiffman M
    N Engl J Med; 2003 Feb; 348(6):489-90. PubMed ID: 12571255
    [No Abstract]   [Full Text] [Related]  

  • 96. Comparisons of HPV DNA detection by MY09/11 PCR methods.
    Castle PE; Schiffman M; Gravitt PE; Kendall H; Fishman S; Dong H; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A; Schussler JE; Burk RD
    J Med Virol; 2002 Nov; 68(3):417-23. PubMed ID: 12226831
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study.
    Stoler MH; Schiffman M;
    JAMA; 2001 Mar; 285(11):1500-5. PubMed ID: 11255427
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
    Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
    J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Natural history of cervicovaginal papillomavirus infection in young women.
    Ho GY; Bierman R; Beardsley L; Chang CJ; Burk RD
    N Engl J Med; 1998 Feb; 338(7):423-8. PubMed ID: 9459645
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.
    Anastos K; Hoover DR; Burk RD; Cajigas A; Shi Q; Singh DK; Cohen MH; Mutimura E; Sturgis C; Banzhaf WC; Castle PE
    PLoS One; 2010 Oct; 5(10):e13525. PubMed ID: 20976000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.